Response to Smith and Brogly et al. commentaries on Zedler et al

Affiliations

¹ Venebio Group, LLC, Richmond, VA, USA.
² UNC Horizons, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Comment

Andrew R Joyce et al. Addiction. 2016 Dec.

. 2016 Dec;111(12):2131-2133.

doi: 10.1111/add.13608.

¹ Venebio Group, LLC, Richmond, VA, USA.
² UNC Horizons, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

No abstract available

Keywords: Buprenorphine; meta-analysis; methadone; opioid use disorder; pregnancy; systematic review.

Comment on

Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, Jones HE. Zedler BK, et al. Addiction. 2016 Dec;111(12):2115-2128. doi: 10.1111/add.13462. Epub 2016 Jun 30. Addiction. 2016. PMID: 27223595 Free PMC article.
The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding?
Brogly SB, Saia K, Hernández-Diaz S, Werler M, Sebastiani P. Brogly SB, et al. Addiction. 2016 Dec;111(12):2130-2131. doi: 10.1111/add.13551. Addiction. 2016. PMID: 28075537 Free PMC article.
Zero is an important number.
Smith L. Smith L. Addiction. 2016 Dec;111(12):2129-2130. doi: 10.1111/add.13529. Addiction. 2016. PMID: 28075540 No abstract available.